408 related articles for article (PubMed ID: 25448765)
21. Interleukin-26, preferentially produced by T
Broux B; Zandee S; Gowing E; Charabati M; Lécuyer MA; Tastet O; Hachehouche L; Bourbonnière L; Ouimet JP; Lemaitre F; Larouche S; Cayrol R; Bouthillier A; Moumdjian R; Lahav B; Poirier J; Duquette P; Arbour N; Peelen E; Prat A
Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32788322
[TBL] [Abstract][Full Text] [Related]
22. Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis.
Uchida Y; Sumiya T; Tachikawa M; Yamakawa T; Murata S; Yagi Y; Sato K; Stephan A; Ito K; Ohtsuki S; Couraud PO; Suzuki T; Terasaki T
Mol Neurobiol; 2019 Mar; 56(3):2039-2056. PubMed ID: 29984400
[TBL] [Abstract][Full Text] [Related]
23. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
[TBL] [Abstract][Full Text] [Related]
24. Astrocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis.
Eilam R; Segal M; Malach R; Sela M; Arnon R; Aharoni R
Glia; 2018 May; 66(5):1098-1117. PubMed ID: 29424049
[TBL] [Abstract][Full Text] [Related]
25. Nav1.5 in astrocytes plays a sex-specific role in clinical outcomes in a mouse model of multiple sclerosis.
Pappalardo LW; Samad OA; Liu S; Zwinger PJ; Black JA; Waxman SG
Glia; 2018 Oct; 66(10):2174-2187. PubMed ID: 30194875
[TBL] [Abstract][Full Text] [Related]
26. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis.
Tonra JR; Reiseter BS; Kolbeck R; Nagashima K; Robertson R; Keyt B; Lindsay RM
J Comp Neurol; 2001 Jan; 430(1):131-44. PubMed ID: 11135250
[TBL] [Abstract][Full Text] [Related]
28. Pathological findings in rats with experimental allergic encephalomyelitis.
Dong M; Liu R; Guo L; Li C; Tan G
APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994
[TBL] [Abstract][Full Text] [Related]
29. Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation.
Tsunoda I; Kuang LQ; Igenge IZ; Fujinami RS
J Neuroimmunol; 2005 Mar; 160(1-2):122-34. PubMed ID: 15710465
[TBL] [Abstract][Full Text] [Related]
30. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
[TBL] [Abstract][Full Text] [Related]
31. Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier.
Shimizu F; Tasaki A; Sano Y; Ju M; Nishihara H; Oishi M; Koga M; Kawai M; Kanda T
PLoS One; 2014; 9(3):e92872. PubMed ID: 24686948
[TBL] [Abstract][Full Text] [Related]
32. Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions.
Ifergan I; Kebir H; Terouz S; Alvarez JI; Lécuyer MA; Gendron S; Bourbonnière L; Dunay IR; Bouthillier A; Moumdjian R; Fontana A; Haqqani A; Klopstein A; Prinz M; López-Vales R; Birchler T; Prat A
Ann Neurol; 2011 Nov; 70(5):751-63. PubMed ID: 22162058
[TBL] [Abstract][Full Text] [Related]
33. Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis.
Errede M; Girolamo F; Ferrara G; Strippoli M; Morando S; Boldrin V; Rizzi M; Uccelli A; Perris R; Bendotti C; Salmona M; Roncali L; Virgintino D
J Neuropathol Exp Neurol; 2012 Oct; 71(10):840-54. PubMed ID: 23001217
[TBL] [Abstract][Full Text] [Related]
34. Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis.
Mizee MR; Nijland PG; van der Pol SM; Drexhage JA; van Het Hof B; Mebius R; van der Valk P; van Horssen J; Reijerkerk A; de Vries HE
Acta Neuropathol; 2014 Nov; 128(5):691-703. PubMed ID: 25149081
[TBL] [Abstract][Full Text] [Related]
35. Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels.
Cunnea P; McMahon J; O'Connell E; Mashayekhi K; Fitzgerald U; McQuaid S
Acta Neuropathol; 2010 May; 119(5):601-15. PubMed ID: 19967542
[TBL] [Abstract][Full Text] [Related]
36. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
[TBL] [Abstract][Full Text] [Related]
37. Blood-brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans.
Mora P; Hollier PL; Guimbal S; Abelanet A; Diop A; Cornuault L; Couffinhal T; Horng S; Gadeau AP; Renault MA; Chapouly C
PLoS Biol; 2020 Nov; 18(11):e3000946. PubMed ID: 33253145
[TBL] [Abstract][Full Text] [Related]
38. B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity.
Klotz L; Kuzmanov I; Hucke S; Gross CC; Posevitz V; Dreykluft A; Schulte-Mecklenbeck A; Janoschka C; Lindner M; Herold M; Schwab N; Ludwig-Portugall I; Kurts C; Meuth SG; Kuhlmann T; Wiendl H
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6182-E6191. PubMed ID: 27671636
[TBL] [Abstract][Full Text] [Related]
39. Dynamics of sodium channel Nav1.5 expression in astrocytes in mouse models of multiple sclerosis.
Pappalardo LW; Liu S; Black JA; Waxman SG
Neuroreport; 2014 Oct; 25(15):1208-15. PubMed ID: 25144393
[TBL] [Abstract][Full Text] [Related]
40. Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases.
Aubé B; Lévesque SA; Paré A; Chamma É; Kébir H; Gorina R; Lécuyer MA; Alvarez JI; De Koninck Y; Engelhardt B; Prat A; Côté D; Lacroix S
J Immunol; 2014 Sep; 193(5):2438-54. PubMed ID: 25049355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
